Home Site Map Contact Us Donate E-mail Newsletter xml  
Condition Critical

Publications

International Activity Report 2004

  • Donate
  • Print
  • E-mail
  • Share

Benin

Helping those with Buruli ulcer

Treating people who suffer from Buruli ulcer remains MSF's principal work in Benin. Buruli ulcer is a bacterial infection related to tuberculosis and leprosy. It causes skin swelling and suppresses the immune system. The infection destroys skin and bone tissue over a wide area of the body. To date, there is neither a medicinal treatment for the disease nor a vaccine to prevent it; surgery to relieve its effects is the only option.

In the town of Lalo, in Mono-Couffo department, MSF runs a treatment center to help those with this illness. The staff diagnose the disease, oversee surgery and help rehabilitate people disabled by it. MSF also teaches local health professionals about diagnostic and curative techniques, with particular emphasis on surgical training. At present, MSF supervises an average of 25 surgical interventions per week. Through operational research, MSF strives, with other partners, to improve care for people with this disease and raise awareness about it so that this care can be integrated into the national health system.

Although official statistics place the HIV/ AIDS prevalence rate at 4.1 percent in Benin, figures differ among regions and population groups. Surveillance of women seeking prenatal care in the town of Dogbo, Mono-Couffo department, revealed a prevalence rate of 7.4 percent. Because this region has no health facility that implements HIV/AIDS-related care, MSF has opened such a program there. The team started by providing voluntary testing, information, and medical consultations for opportunistic infections. By the end of 2003, MSF had signed an agreement to launch a treatment program using lifeextending antiretroviral (ARV) therapy in this rural area. In the second half of 2004, in Dogbo, MSF will begin to treat patients with ARVs and start a program to prevent mother-to-child transmission of the disease. MSF's goal is for 300 of its patients to be taking ARVs by the end of 2004.

MSF has worked in Benin since 1997.

MSF Projects 2004